This site uses cookies for analytics, personalized content and ads. By continuing to browse this site, you agree to this use of cookies in accordance with our Cookie Policy.

CAQ Snapshot: July 2020

Thursday, July 30, 2020

The COVID-19 pandemic and volatile market conditions create many new uncertainties for financial reporting stakeholders. The CAQ’s new webisode series launched last month can help you confidently navigate this new normal with timely insights from top leaders in the profession. Here is a sample of the latest webisodes focused on the Q2 financial reporting season.

SEC Coronavirus Steering Committee

The CAQ’s Margot Cella, Vice President, Research and Anti-Fraud Initiatives, interviews the SEC Division of Enforcement’s Associate Director, Carolyn Welshhans, about the SEC Coronavirus Steering Committee’s priorities, enforcements of fraud during the pandemic, and efforts to deter fraud in the coming months.

Going Concern

The pandemic and the resulting economic uncertainty has caused several companies to face unprecedented challenges such as work stoppages, supply chain disruptions, new regulations, and reduced consumer spending. Such challenges could impact entities’ ability to continue operating as a going concern. CAQ’s Yuri Zwick, Professional Practice Fellow, sits down with Jackie Daylor, National Managing Partner of Audit Quality and Professional Practice at KPMG and Rich Davisson Assurance Partner and Director at RSM, to discuss going concern considerations in the COVID-19 environment and to share related insights from the calendar Q1 2020 reporting cycle.


Ever wonder why non-GAAP reporting is so important to investors? Dennis McGowan, Senior Director, Professional Practice, CAQ, leads an in-depth discussion with Todd Castagno, Executive Director, Research, Morgan Stanley, and Steven Jacobs, Partner, Americas Director, SEC Regulatory Matters and Capital Markets, EY to discuss why non-GAAP reporting is so important, observations on company considerations related to Non-GAAP during the pandemic, and early perspectives on Q2 reporting and beyond.

In case you missed these webisodes from last month: